Decision: Favourable
Study Title:
IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24- Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients with Pulmonary Arterial Hypertension (PAH)
NREC Code:
22-NREC-CT-154
Decision:
Favourable
Meeting Date:
05/10/2022
Study Type:
CT application
Principal Investigator:
Prof Sean Gaine
PI Institution:
Mater Misericordiae University Hospital
Sponsor:
Aerovate Therapeutics, Inc